# US 2001/0056301 A1 · Hydrogel biomedical articles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0056301 A1
- Document ID: US20010056301A1
- Status: Published application
- Kind: A1
- Application number: 09/805,483
- Filed: 2001-03-13
- Published: 2001-12-27
- Earliest claimed: 2000-03-13
- Assignees: BioCure, Inc.
- Inventors: Dennis W. Goupil; Hassan Chaouk; Troy Holland; Bruktawit T. Asfaw; Stephen D. Goodrich; Lucas Latini
- Web page: https://patentgrep.com/patent/US20010056301A1

## CPC

- C08L 51/003: {grafted on to macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds (C08L51/04, C08L51/06 take precedence)}
- A61B 17/12022: {Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20)}
- A61B 17/12099: {characterised by the location of the occluder}
- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61B 17/12186: {liquid materials adapted to be injected}
- A61B 17/1219: {expandable in contact with liquids}
- A61L 15/24: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 24/0031: {Hydrogels or hydrocolloids}
- A61L 24/06: obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/34: Macromolecular materials
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 29/041: {obtained by reactions only involving carbon-to-carbon unsaturated bonds}
- A61L 29/085: {Macromolecular materials}
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- C08F 8/30: Introducing nitrogen atoms or nitrogen-containing groups
- C08F 261/00: Macromolecular compounds obtained by polymerising monomers on to polymers of oxygen-containing monomers as defined in group C08F16/00
- C08F 261/04: on to polymers of vinyl alcohol
- C08F 271/02: on to polymers of monomers containing heterocyclic nitrogen
- C08F 277/00: Macromolecular compounds obtained by polymerising monomers on to polymers of carbocyclic or heterocyclic monomers as defined respectively in group C08F32/00 or in group C08F34/00
- C08F 290/00: Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F 290/12: Polymers provided for in subclasses C08C or C08F
- C08F 290/14: Polymers provided for in subclass C08G
- C08L 51/08: grafted on to macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
- A61L 2430/36: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

Hydrogel biomedical articles formed from macromers having a polymeric backbone comprising 1,2-diol and/or 1,3-diol units, such as polyvinyl alcohol, and pendant chains bearing crosslinkable groups and, optionally, other modifiers.

## Claims

### Claim 1

A hydrogel biomedical article formed from macromers having a polymeric backbone comprising units having a 1,2-diol or 1,3-diol structure and at least two pendant chains bearing crosslinkable groups.

### Claim 2 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the backbone polymer is a polyhydroxy polymer.

### Claim 3 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the pendant chains bearing crosslinkable groups are attached to the backbone via the 1,2-diol or 1,3-diol groups.

### Claim 4 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the pendant chains bearing crosslinkable groups are attached to the backbone via cyclic acetal linkages.

### Claim 5 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the backbone polymer comprises poly(vinyl alcohol) (PVA) and copolymers thereof.

### Claim 6 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the macromer has the formula:
10
in which R is a linear or branched C1-C8 alkylene or a linear or branched C1-C12 alkane; R1 is hydrogen, a C1-C6 alkyl, or a cycloalkyl; R2 is hydrogen or a C1-C6 alkyl; and R3 is an olefinically unsaturated electron attracting copolymerizable radical having up to 25 carbon atoms.

### Claim 7 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the macromer further comprises pendant modifier groups.

### Claim 8 (depends on 1)

The hydrogel biomedical article of claim 1, further comprising an active agent.

### Claim 9 (depends on 8)

The hydrogel biomedical article of claim 8, wherein the hydrogel releases the active agent over a period of time ranging from about 1 day to 6 months.

### Claim 10 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the hydrogel is biodegradable.

### Claim 11 (depends on 1)

The hydrogel biomedical article of claim 1, further comprising a contrast agent.

### Claim 12 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the crosslinkable groups are crosslinked via free radical polymerization.

### Claim 13 (depends on 11)

The hydrogel biomedical article of claim 11, wherein the free radical polymerization is redox initiated.

### Claim 14 (depends on 12)

The hydrogel biomedical article of claim 12, wherein the crosslinkable groups are olefinically unsaturated groups.

### Claim 15 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the article is selected from the group consisting of a catheter, tubing, vascular graft, heart valve, suture, prosthesis, dialysis membrane, filter, sensor, wound dressing, and drug delivery article.

### Claim 16 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the article is a microsphere.

### Claim 17 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the hydrogel is a coating on the article.

### Claim 18 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the article is formed in a mold.

### Claim 19 (depends on 1)

The hydrogel biomedical article of claim 1, wherein the article is formed on a substrate.

### Claim 20

A method of making hydrogel biomedical articles comprising crosslinking macromers having a polymeric backbone comprising units having a 1,2-diol or 1,3-diol structure and at least two pendant chains bearing crosslinkable groups.

### Claim 21 (depends on 20)

The method of claim 20, wherein the backbone polymer is a polyhydroxy polymer.

### Claim 22 (depends on 20)

The method of claim 20, wherein the pendant chains bearing crosslinkable groups are attached to the backbone via the 1,2-diol or 1,3-diol groups.

### Claim 23 (depends on 20)

The method of claim 20, wherein the pendant chains bearing crosslinkable groups are attached to the backbone via cyclic acetal linkages.

### Claim 24 (depends on 20)

The method of claim 20, wherein the polymer comprises poly(vinyl alcohol) (PVA) and copolymers thereof.

### Claim 25 (depends on 20)

The method of claim 20, wherein the macromer has the formula:
11
in which R is a linear or branched C1-C8 alkylene or a linear or branched C1-C12 alkane; R1 is hydrogen, a C1-C6 alkyl, or a cycloalkyl; R2 is hydrogen or a C1-C6 alkyl; and R3 is an olefinically unsaturated electron attracting copolymerizable radical having up to 25 carbon atoms.

### Claim 26 (depends on 20)

The method of claim 20, wherein the macromer further comprises pendant modifier groups.

### Claim 27 (depends on 20)

The method of claim 20, further comprising administering an active agent.

### Claim 28 (depends on 27)

The method of claim 27, wherein the active agent is encapsulated in the hydrogel.

### Claim 29 (depends on 28)

The method of claim 28, wherein the hydrogel releases the active agent over a period of time ranging from about 1 day to 6 months.

### Claim 29 (depends on 20)

The method of claim 20, wherein the hydrogel is biodegradable.

### Claim 30 (depends on 20)

The method of claim 20, further comprising administering a contrast agent.

### Claim 31 (depends on 20)

The method of claim 20, wherein the crosslinkable groups are crosslinked via free radical polymerization.

### Claim 32 (depends on 20)

The method of claim 20, wherein the free radical polymerization is redox initiated.

### Claim 33 (depends on 20)

The method of claim 20, wherein the crosslinkable groups are olefinically unsaturated groups.

### Claim 34 (depends on 20)

The method of claim 20, wherein the article is selected from the group consisting of a catheter, tubing, vascular graft, heart valve, suture, prosthesis, dialysis membrane, filter, sensor, wound dressing, and drug delivery article.

### Claim 35 (depends on 20)

The method of claim 20, wherein the article is a microsphere.

### Claim 36 (depends on 20)

The method of claim 20, wherein the hydrogel is formed as a coating on the article.

### Claim 37 (depends on 20)

The method of claim 20, wherein the article is formed in a mold.

### Claim 38 (depends on 20)

The method of claim 20, wherein the article is formed on a substrate.
